Publications by authors named "Charles Conrad"

Claim this Profile
P
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
Stefania Maraka, Morris D Groves, Aaron G Mammoser, Isaac Melguizo-Gavilanes, Charles A Conrad

Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.
Frederick F Lang, Charles Conrad, Candelaria Gomez-Manzano, W K Alfred Yung, Raymond Sawaya

J Clin Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastoma.
Shiao-Pei Weathers, Xiaosi Han, Diane D Liu, Charles A Conrad, Mark R Gilbert

J Neurooncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression and prognostic impact in glioblastoma.
Edjah K Nduom, Jun Wei, Nasser K Yaghi, Neal Huang, Ling-Yuan Kong, Charles A Conrad

Neuro Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors.
James A Bankson, Christopher M Walker, Marc S Ramirez, Wolfgang Stefan, David Fuentes, Charles A Conrad

Cancer Res· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice.
Sun-Jin Kim, Ho Jeong Lee, Mark Seungwook Kim, Hyun Jin Choi, Junqin He, Charles A Conrad

Clin Cancer Res· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of HBV-specific CD8(+) T cell-mediated inflammation is diversified in different clinical presentations of HBV infection.
Colin M Dinney, Lu-Dong Zhao, Charles D Conrad, Jay M Duker, Richard O Karas

J Microbiol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wound healing complications in brain tumor patients on Bevacizumab.
Harshad Ladha, Tushar Pawar, Mark R Gilbert, Jacob Mandel, Barbara O-Brien, Charles Conrad

J Neurooncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpoints.
Hong Jiang, Candelaria Gomez-Manzano, Yisel Rivera-Molina, Frederick F Lang, Charles A Conrad

Curr Opin Virol· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Modulation of Neurocognitive Function in Glioma Patients.
Yanhong Liu, Renke Zhou, Erik P Sulman, Michael E Scheurer, Nicholas Boehling, Charles A Conrad

Clin Cancer Res· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stat3 orchestrates interaction between endothelial and tumor cells and inhibition of Stat3 suppresses brain metastasis of breast cancer cells.
Hsueh-Te Lee, Jianfei Xue, Ping-Chieh Chou, Aidong Zhou, Phillip Yang, Charles A Conrad

Oncotarget· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
Marta Penas-Prado, Kenneth R Hess, Michael J Fisch, Lore W Lagrone, Morris D Groves, Charles A Conrad

Neuro Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targets in subependymoma.
Ling-Yuan Kong, Jun Wei, Ali S Haider, Brandon D Liebelt, Xiaoyang Ling, Charles A Conrad

J Neuroimmunol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy and glial brain tumors.
Shlomit Yust-Katz, John F de Groot, Diane Liu, Jimin Wu, Ying Yuan, Charles A Conrad

Neuro Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of inflammation in brain cancer.
James L Sowers, Kenneth M Johnson, Charles Conrad, Joel T Patterson, Lawrence C Sowers

Adv Exp Med Biol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.
Mohamed A Hamza, Jacob J Mandel, Charles A Conrad, Mark R Gilbert, W K Alfred Yung

J Neurooncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral heterogeneity and intraclonal plasticity: from warburg to oxygen and back again.
Charles A Conrad, Juan Fueyo, Candelaria Gomez-Manzano

Neuro Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes.
Konrad Gabrusiewicz, Dan Liu, Nahir Cortes-Santiago, Mohammad B Hossain, Charles A Conrad

Oncotarget· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative biological analysis for neuropsychopharmacology.
Mark R Emmett, Roger A Kroes, Joseph R Moskal, Charles A Conrad, Waldemar Priebe

Neuropsychopharmacology· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated chromosome 19 transcriptomic and proteomic data sets derived from glioma cancer stem-cell lines.
Cheryl F Lichti, Huiling Liu, Alexander S Shavkunov, Ekaterina Mostovenko, Erik P Sulman, Charles A Conrad

J Proteome Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma.
Shlomit Yust-Katz, Diane Liu, Ying Yuan, Vivien Liu, Sanghee Kang, Charles Conrad

Cancer· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
D-Glucose and D-mannose-based metabolic probes. Part 3: Synthesis of specifically deuterated D-glucose, D-mannose, and 2-deoxy-D-glucose.
Izabela Fokt, Stanislaw Skora, Charles Conrad, Timothy Madden, Mark Emmett

Carbohydr Res· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromosome 19 annotations with disease speciation: a first report from the Global Research Consortium.
Carol L Nilsson, Frode Berven, Frode Selheim, Huiling Liu, Joseph R Moskal, Charles A Conrad

J Proteome Res· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients.
David A Reardon, Charles A Conrad, Timothy Cloughesy, Michael D Prados, Henry S Friedman

Cancer Chemother Pharmacol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway.
Ke Sai, Shuzhen Wang, Veerakumar Balasubramaniyan, Charles Conrad, Frederick F Lang

J Neurooncol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis